135 related articles for article (PubMed ID: 21598414)
1. Efficacy and safety of orally administered Lentinula edodes mycelia extract for patients undergoing cancer chemotherapy: a pilot study.
Yamaguchi Y; Miyahara E; Hihara J
Am J Chin Med; 2011; 39(3):451-9. PubMed ID: 21598414
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of orally administered Lentinula edodes mycelia extract for advanced gastrointestinal cancer patients undergoing cancer chemotherapy: a pilot study.
Okuno K; Uno K
Asian Pac J Cancer Prev; 2011; 12(7):1671-4. PubMed ID: 22126542
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of oral administration of Lentinula eododes mycelia extract for breast cancer patients undergoing postoperative hormone therapy.
Suzuki N; Takimoto Y; Suzuki R; Arai T; Uebaba K; Nakai M; Strong JM; Tokuda H
Asian Pac J Cancer Prev; 2013; 14(6):3469-72. PubMed ID: 23886130
[TBL] [Abstract][Full Text] [Related]
4. Improvement of QOL and Immunological Function With Lentinula Edodes Mycelia in Patients Undergoing Cancer Immunotherapy: An Open Pilot Study.
Tanigawa K; Itoh Y; Kobayashi Y
Altern Ther Health Med; 2016 Jul; 22(4):36-42. PubMed ID: 27548491
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of quality of life and immune function in cancer patients receiving combined immunotherapy and oral administration of lentinula edodes mycelia extract].
Tanigawa K; Ito Y; Sakai M; Kobayashi Y
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1779-81. PubMed ID: 23267884
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of host quality of life and immune function in breast cancer patients treated with combination of adjuvant chemotherapy and oral administration of Lentinula edodes mycelia extract.
Nagashima Y; Maeda N; Yamamoto S; Yoshino S; Oka M
Onco Targets Ther; 2013; 6():853-9. PubMed ID: 23874107
[TBL] [Abstract][Full Text] [Related]
7.
Nagashima Y; Yoshino S; Yamamoto S; Maeda N; Azumi T; Komoike Y; Okuno K; Iwasa T; Tsurutani J; Nakagawa K; Masaaki O; Hiroaki N
Mol Clin Oncol; 2017 Sep; 7(3):359-366. PubMed ID: 28811898
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23.
Land SR; Kopec JA; Yothers G; Anderson S; Day R; Tang G; Ganz PA; Fisher B; Wolmark N
Breast Cancer Res Treat; 2004 Jul; 86(2):153-64. PubMed ID: 15319567
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of
Yanagimoto H; Hirooka S; Yamamoto T; Yamaki S; Sekimoto M
Nutr Cancer; 2023; 75(1):236-246. PubMed ID: 35950537
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.
Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L
Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567
[TBL] [Abstract][Full Text] [Related]
11. Modulatory effects of supplementation of Lentinula edodes mycelia extract and l-arginine on the therapeutic efficacy of immunogenic chemotherapy in colon cancer-bearing mice.
Taniura T; Ishitobi K; Hidaka M; Harada M
Microbiol Immunol; 2024 Jan; 68(1):15-22. PubMed ID: 37964433
[TBL] [Abstract][Full Text] [Related]
12. Anxiety and quality of life of women who receive radiation or chemotherapy for breast cancer.
Schreier AM; Williams SA
Oncol Nurs Forum; 2004; 31(1):127-30. PubMed ID: 14722597
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
14. Oral ingestion of Lentinula edodes mycelia extract can restore the antitumor T cell response of mice inoculated with colon-26 cells into the subserosal space of the cecum.
Tanaka K; Matsui Y; Ishikawa S; Kawanishi T; Harada M
Oncol Rep; 2012 Feb; 27(2):325-32. PubMed ID: 22086364
[TBL] [Abstract][Full Text] [Related]
15. A repeated dose 28-day oral toxicity study of extract from cultured Lentinula edodes mycelia in Wistar rats.
Yoshioka Y; Tamesada M; Tomi H
J Toxicol Sci; 2010 Oct; 35(5):785-91. PubMed ID: 20930474
[TBL] [Abstract][Full Text] [Related]
16. Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial.
Semiglazov VF; Stepula VV; Dudov A; Schnitker J; Mengs U
Anticancer Res; 2006; 26(2B):1519-29. PubMed ID: 16619567
[TBL] [Abstract][Full Text] [Related]
17. Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients.
Kool M; Fontein DB; Meershoek-Klein Kranenbarg E; Nortier JW; Rutgers EJ; Marang-van de Mheen PJ; van de Velde CJ
Breast; 2015 Jun; 24(3):224-9. PubMed ID: 25704982
[TBL] [Abstract][Full Text] [Related]
18. [Outpatient chemotherapy with continuous infusion of 5-fluorouracil (CI 5-FU) and intravenous bolus leucovorin (IVB LV) in advanced gastrointestinal cancer: the second report].
Tsuji Y; Yoshihito H; Nakamura T; Watanabe Y; Nakayama N; Ohi M; Kawanishi J; Handa H; Honjo K; Uehara S
Gan To Kagaku Ryoho; 1995 Dec; 22 Suppl 4():439-46. PubMed ID: 8849290
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of EORTC QLQ-C30 questionnaire in patients undergoing in-hospital chemotherapy for gastrointestinal cancer in Japan.
Kato J; Nagahara A; Iijima K; Yoshimura M; Osada T; Yoshizawa T; Watanabe S
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S268-72. PubMed ID: 19120910
[TBL] [Abstract][Full Text] [Related]
20. MS-20, a chemotherapeutical adjuvant, reduces chemo-associated fatigue and appetite loss in cancer patients.
Chi KH; Chiou TJ; Li CP; Chen SY; Chao Y
Nutr Cancer; 2014; 66(7):1211-9. PubMed ID: 25256137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
